What the Certificate Does Not Say: Interpreting Antibody Stability Evidence in UK Laboratories
A vendor stability certificate often arrives as a clean table: storage condition, time point, remaining activity, expiry. It is a useful document, but it is not a shelf-life guarantee for every laboratory that receives the antibody. As of 2026, UK antibody laboratories operate within complex supply chains, automated diagnostic platforms and accreditation expectations that place the burden of interpretation on the receiving organisation. The certificate describes the material and conditions tested by the supplier. The laboratory must decide whether those conditions resemble its own.
Start with the evidence type
Real-time stability data at the intended storage temperature remain the strongest basis for a shelf-life claim. They reflect the product as supplied, in its stated container, over a defined period. Accelerated studies, by contrast, use elevated temperatures to compress time. They are valuable for screening formulations, comparing candidates and identifying degradation pathways, but they are not a substitute for real-time evidence.
Accelerated studies frequently rely on Arrhenius modelling, which assumes a predictable relationship between temperature and degradation rate. Antibodies do not always behave as simple first-order systems. Aggregation, fragmentation, conformational change and loss of binding can follow different kinetics, and a single elevated-temperature condition may not represent the stresses of transport or repeated freezer excursions. For a UK laboratory, the practical rule is straightforward: use accelerated data to ask better questions, not to award a longer expiry date.
Transport is part of the study
An antibody can be stable for 24 months at 2–8 °C and still fail in transit. UK laboratories receive reagents through courier networks, border holds and seasonal temperature variation. A supplier stability study may not include the distribution route, the packing configuration or the duration of exposure outside controlled conditions. Dry-ice sublimation, delayed customs clearance and summer ambient temperatures can all create excursions that the certificate never describes.
Receipt inspection should therefore include more than a visual check. Temperature-logger data, packing condition and time in transit are part of the evidence. Where an excursion has occurred, the laboratory should not simply reset the clock. It should assess the deviation against the supplier's stated tolerances and, where necessary, perform a bridging study before the reagent enters routine use.
Reconstitution changes the question
Lyophilised antibodies and liquid antibodies do not share the same stability profile. Once a lyophilised product is reconstituted, the relevant conditions are those of the laboratory's diluent, container and storage regime. A shelf-life claim for the supplied powder may say little about the reconstituted working stock. Similarly, a concentrated liquid antibody may behave differently once diluted into an assay buffer or held on board an automated platform.
UK diagnostic workflows often involve in-use stability that the vendor never tested: reagent onboard a analyser, repeated aspiration, exposure to system fluids, or storage in a laboratory-prepared aliquot. These are internal variables. They require internal evidence.
Read the data package critically
A useful stability package should identify the lots tested, the formulation, the container and closure, the storage orientation, the time points and the analytical methods. It should also state acceptance criteria. Binding assays alone may not detect aggregation or fragmentation; appearance alone may not detect loss of function. For diagnostic antibodies, stability-indicating methods should include a functional readout alongside physicochemical characterisation.
A single lot with limited time points is weaker evidence than multiple lots tested against pre-defined criteria. The laboratory should ask whether the study is representative of the material it receives and whether the methods are sensitive enough to detect the degradation that matters for its assay.
Freeze-thaw and routine handling
Repeated freeze-thaw is a common laboratory stress, but it is not always represented in vendor studies. Frost-free freezers, door openings, small aliquot volumes and variable thawing practice can all affect performance. Where the supplier has not tested a freeze-thaw cycle that resembles routine use, the laboratory should generate its own evidence or adopt a conservative internal expiry.
From claim to internal expiry
UK laboratories should distinguish three dates: the supplier's expiry, the internal receipt date and the in-use expiry after reconstitution or dilution. The internal expiry should be risk-based and documented. It may be shorter than the supplier's claim where transport, reconstitution or handling introduces uncertainty. It should not be longer without supporting data.
Bridging studies are the appropriate tool when a new lot, formulation or storage condition is introduced. A side-by-side comparison against a qualified reference material, using the same method and acceptance criteria, provides more defensible evidence than an assumption that the certificate transfers unchanged. For UK diagnostic developers and accredited laboratories, change control should capture the rationale, the evidence and the approved expiry.
A practical checklist
- Confirm whether the claim is based on real-time or accelerated data.
- Check that the tested formulation, concentration and container match the received material.
- Review transport conditions and any recorded excursion.
- Establish a separate in-use expiry after reconstitution or dilution.
- Verify that stability-indicating methods include a functional binding readout.
- Use bridging studies for new lots, formulations or storage regimes.
- Document a conservative internal expiry where evidence is incomplete.
The stability certificate is a starting point for assessment, not the end of it. In UK antibody laboratories, the defensible expiry date is the one supported by evidence that matches the material, the handling and the intended use. Reading the certificate carefully is the first step; bridging the gap between supplier data and local practice is the work that follows.
